Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
308.01 -3.99 / -1.28%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
306.11 -1.90 / -0.62%
 
Volume: 21.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Operating ActivitiesNet Income / Starting Line-1.0B-732.9M-512.3M-241.6M
 
 
 
 
 
Depreciation938.2M938.0M982.6M1.7B
 
 
 
 
 
Total Other Cash Flow979.1M861.7M781.0M961.8M
 
 
 
 
 
Funds From Operations613.5M789.2M947.0M2.2B
 
 
 
 
 
Funds From/For Other Operating Expenses91.2M-22.4M422.0M783.1M
 
 
 
 
 
Net Cash Flow - Operating Activities522.3M811.6M525.0M1.4B
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.0M-15.0M-6.0M
 
 
 
 
Decrease In Investments1.5M10.5M----
 
 
 
Capital Expenditures-93.3M-64.5M-136.6M-111.6M
 
 
 
 
 
Fixed Asset Disposal7.8M1.7M74.9M6.6M
 
 
 
 
 
Net Assets From Acquisitions -4.8B-639.7M-34.6B-463.7M
 
 
 
 
 
Other Investing - Sources433.2M-9.5M790.5M65.3M
 
 
 
 
 
Net Cash Flow Investing-4.5B-738.5M-33.9B-529.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings4.4B1.0B29.0B72.8M
 
 
 
 
 
Long Term Debt Reduction-4.4B-1.3B-2.7B-1.4B
 
 
 
 
 
Net Proceeds Stock Sale35.2M62.6M9.0B65.6M
 
 
 
 
 
Common Preferred Redeemed-40.3M-30.4M-64.1M-36.9M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00-68.7M
 
 
Other Sources - Financing0.0028.4M36.1M200.0K
 
 
 
 
Other Uses - Financing4.8M1.7M24.6M67.4M
 
 
 
 
 
Net Cash Flow - Financing-23.9M-158.7M35.3B-1.5B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.7M-3.8M-4.8M1.7M
 
 
 
 
 
 
Net Change In Cash-4.0B-85.6M1.9B-598.7M